definiens: ), and the SOPs as defined in Secti ons 6.2 . All Cryo shall be produced only at the Precision Pharma Services Faci lity . The Specifications shall be renewed annually, consistent with the Term of this Agreement, with each such renewal deemed attached hereto as EXHIBIT C an d incorporated herein by reference . In the event of a conflict between the p rovisions of this Agreement and the provisions of the Specifications, the provi sions of this Agreement shall prevail . Talecris / Precision shall not make changes to the key process parameters EXHIBIT D that require prior approval from the FDA or the Specifications without prior reasonable notice to Customer, which prior no tice shall be at least six ( 6 ) months unless otherwise required by a regulator y body . Such notice shall be sufficiently prior to implementation of the changes so as to allow Customer to amend its regulatory filings and to purchase additi onal inventory of Cryo